Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am hoping for share buy backs....

You and PTSC would be taking for granted successful Reexams.. because without them, PTSC would then find themselves upside down on a tunkload of stock... I guess PTSC could continue to 'average down'..

I suppose the stock could still be use for M&A.. tho no where near as efficiently.. as Appeal of unexpected Reexam results would be undertaken.

Could the Reexam process be having a deleterious (even if unwarranted) affect on our M&A process?

Share
New Message
Please login to post a reply